[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369445-105":59,"doc-detail-369445-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-clinicopathological-features-of-breast-cancer-in-peutz-jeghers-syndrome-results-from-an-international-survey","The clinicopathological features of breast cancer in Peutz-Jeghers syndrome - results from an international survey","","Study evaluates clinicopathological characteristics and outcomes of breast cancer in Peutz-Jeghers syndrome (PJS), a rare autosomal dominant condition with elevated breast cancer risk and recommended surveillance. An international retrospective survey collected data from InSiGHT members on PJS patients with diagnosed breast cancer. Twenty-three responses yielded 27 patients and 34 breast cancers, all female. Most were ductal carcinoma, predominantly ER/PR positive, with no triple-negative tumors; 5-year survival was 73% and follow-up included 229 patient-years.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-clinicopathological-features-of-breast-cancer-in-peutz-jeghers-syndrome-results-from-an-international-survey/369445/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-clinicopathological-features-of-breast-cancer-in-peutz-jeghers-syndrome-results-from-an-international-survey/369445.png","ImageObject",300,407,{"name":92,"@type":93},"Kyle","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study purpose regarding breast cancer in Peutz-Jeghers syndrome?","Question",{"text":112,"@type":113},"To evaluate clinicopathological features and prognosis data in PJS breast cancer patients, supporting more precise future guideline development for risk management and surveillance decisions.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the study data collected?",{"text":117,"@type":113},"Through an international retrospective survey of InSiGHT members to collect data on PJS patients with diagnosed breast cancer from participating centers.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the key findings about tumor characteristics and survival?",{"text":121,"@type":113},"All reported breast cancer patients were female; most cancers were ductal carcinoma (invasive or DCIS). Tumors with histology showed mainly ER-positive and PR-positive results, HER2 positivity in a subset, no triple-negative cancers, and 5-year survival was 73% based on follow-up data.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369445,1790360280,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},3985741905716,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Familial Cancer (2025) 24:41  \n[https://doi.org/10.1007/s10689-025-00469-5](https://doi.org/10.1007/s10689-025-00469-5)  \nORIGINAL ARTICLE  \nThe clinicopathological features of breast cancer in Peutz-Jeghers syndrome: results from an international survey  \nElizabeth Loehrer1 · Anja Wagner1 · Massiah Bahar2 · F. Rubab Ramzan3 · Anne Marie Jelsig4 · Anne Goverde1 · Monique van Leerdam5 · Susanne E. Korsse6 · Evelien Dekker7 · Manon C. W. Spaander8 ·  \nJohn Gásdal Karstensen4,11,12 · Veronica Zuber9 · Finlay Macrae3 · Andrew Latchford2,10  \nReceived: 21 January 2025 / Accepted: 16 April 2025 / Published online: 3 May 2025 © The Author(s) 2025  \nAbstract  \nBackground: Female patients with Peutz-Jeghers syndrome (PJS) have an increased risk of breast cancer (BrCa), and surveillance is recommended. However, clinicopathological features of their tumors and prognosis are lacking. To facilitate more precise future guideline development, we evaluated these data. Methods: We conducted an international survey for InSiGHT members to collect retrospective data on PJS patients with diagnosed breast cancer. Results: We received 23 responses, including three centers with data on BrCa patients. All reported BrCa patients were female. In total, the cohort comprised 27 patients with 34 BrCa (five bilateral synchronous, one bilateral metachronous, and one metachronous unilateral tumours) . The median age at first cancer diagnosis was 45 years (range 26–67) . Most cancers were ductal carcinoma, either invasive (13) or in situ (DCIS; 19) . TNM staging for invasive cancer was available in thirteen cases, of which nine were T1N0M0 . Among tumors with histological reports, 14/15 were oestrogen receptor positive, 8/15 were progesterone receptor positive, and 4/15 were HER2 positive. There were no triple negative breast cancers. Twenty-five patients had follow-up data, comprising 229 patient years. Eleven patients had died of any cause during follow-up. Survival at 5 years was 73% . Conclusion: Overall, breast cancers that occur in this PJS population seem to have favorable characteristics and prognosis. These data will help inform discussions about risk management in patients with PJS. Further research is needed to better understand lifetime risk, the optimal surveillance modality and its outcomes.  \nKeywords Genetic cancer predisposition · Peutz-Jeghers syndrome · Breast cancer · Hereditary cancer syndromes · Germline pathogenic variants  \n􀀍 Andrew Latchford [andrew.latchford@nhs.net](andrew.latchford@nhs.net)  \n1 Department of Clinical Genetics, Erasmus MC Cancer Institute, Rotterdam, Netherlands  \n2 St Mark’s Hospital, Harrow, UK  \n3 Royal Melbourne Hospital, Melbourne, Australia  \n4 Department of Clinical Genetics, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark  \n5 Netherlands Cancer Institute, Amsterdam, Netherlands  \n6 Frisius Medical Center, Leeuwarden, The Netherlands  \n7 Amsterdam UMC, Amsterdam, Netherlands  \n8 Department of Gastroenterology & Hepatology, Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands  \n9 Breast Surgery Unit, University and Research Hospital San Raffaele, Milan, Italy  \n10 Department of Surgery and Cancer, Faculty of Medicine, Imperial College, London SW7 2AX, UK  \n11 Danish Polyposis Register, Gastro Unit, Copenhagen University Hospital-Amager and Hvidovre, Hvidovre, Denmark  \n12 Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark  \nIntroduction  \nPeutz-Jeghers syndrome (PJS) is a rare autosomal dominant inherited disorder, caused by a constitutional pathogenic variant (PV) in the tumour suppressor gene STK11 (also known as LKB1) [1, 2] and clinically characterized by the development of Peutz-Jegher type hamartomatous polyps in the gastrointestinal tract, mucocutaneous pigmentation [3–5] The estimated prevalence of PJS is most consistently reported to be somewhere between 1 in 50,000 to 1 in 200,000, with a wider range of estimates from","cbCaiq8bMkaefBvp","https://ap.wps.com/l/cbCaiq8bMkaefBvp","pdf",1022923,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Disease background and cancer risk\n## Surveillance recommendations","[{\"question\":\"What was the study purpose regarding breast cancer in Peutz-Jeghers syndrome?\",\"answer\":\"To evaluate clinicopathological features and prognosis data in PJS breast cancer patients, supporting more precise future guideline development for risk management and surveillance decisions.\"},{\"question\":\"How were the study data collected?\",\"answer\":\"Through an international retrospective survey of InSiGHT members to collect data on PJS patients with diagnosed breast cancer from participating centers.\"},{\"question\":\"What were the key findings about tumor characteristics and survival?\",\"answer\":\"All reported breast cancer patients were female; most cancers were ductal carcinoma (invasive or DCIS). Tumors with histology showed mainly ER-positive and PR-positive results, HER2 positivity in a subset, no triple-negative cancers, and 5-year survival was 73% based on follow-up data.\"}]","The clinicopathological features of breast cancer in Peutz-Jeghers syndrome - results from an international survey | PDF",1790182720,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1d93e1950e155c53e0d755309808d195.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/26f8432785c818d6d7926914bf3f074a.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7845d5f65b9cbbdbf707e9748aa571ee.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b34f6848b1f54abf6575ac8ef5d245fc.webp",980,1301]